Insider trades
Otis W. Brawley, Director of Lyell Immunopharma LYEL, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/10.
Otis W. Brawley
Director
- Company
- Lyell Immunopharma LYEL
- First filing
- 23/03/20
- Trades
- 26 trades
- Buys / sales
- 1 / 0
- 12-month net buying
- No record
- Last trade
- 06/10
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/03/31 | 25/04/02 | 35,640 sh | $0.56 | $19,958.4 | No record |